JAZZ PHARMACEUTICAL PARTNERS WITH WESTWOOD & WILSHIRE TO FILL VICE PRESIDENT OF HEMATOLOGY ONCOLOGY CLINICAL

Dr. Anne Borgman-Hagey has joined Jazz Pharmaceuticals as their new Vice President & Head of Hematology-Oncology Clinical Development. Dr. Borgman joined from Exelixis Biopharmaceuticals where she was the Vice President of R&D. Dr. Anne Borgman held senior executive level roles including CMO of KaloBios Pharmaceuticals, CMO of Talon Therapeutics and Global Project Head, Oncology at Abbott Laboratories.

The search was successfully led by Tamir Halaban. 

At Westwood & Wilshire, we recognize that people are an organization's top asset. We are passionate about delivering premier talent to the world’s most innovative companies. We are particularly focused on companies ranging from VC-backed start-ups to mid-sized commercial entities and our assignments range from C-Suite to mid-management. Based in Los Angeles, California, with offices in Silicon Valley, we serve clients on a local, national and global basis.